Reasons Why the USP Postponement Has Been Postponed The revised USP rulings have been postponed for now due to appeals by a number of bodies, namely The National Community Pharmacists Association (NCPA), International Academy of Compounding Pharmacists (IACP) and more than 30 other pharmacist associations. The appeals have been made due to data restrictions, and
Read more
1 June 2019 saw the publication of new and revised USP 797 standards, with affected users being expected to ensure their compliance with the new requirements by 1 December 2019. The recently revised standards tighten up controls in some areas which directly impact the safety and quality of compounded medicines. The latest changes affect 5
Read more
USP General Chapter provides standards for safe handling of hazardous drugs to minimize the risk of exposure to healthcare personnel, patients and the environment. The National Institute for Occupational Safety and Health (NIOSH) considers a drug to be hazardous if it exhibits one or more of the following characteristics in humans or animals: carcinogenicity, teratogenicity
Read more
Millions of medications are compounded each year in the US to meet the unique needs of patients. Compounding provides access to medication for patients who may not be able to use commercially available formulations due to dosing requirements, allergies or rare diseases. Medications that are required to be sterile include those administered through injection, intravenous
Read more